Importance of Hospital Volume in the Overall Management of Pancreatic Cancer
Authors:
- Helen M. BowmanHBHelen M. Bowman
- Toby A. GordonTGToby A. Gordon
- Eric B. BassEBEric B. Bass
- Charles J. YeoCYCharles J. Yeo
- Keith D. LillemoeKLKeith D. Lillemoe
- Henry A. PittHPHenry A. Pitt
- James M. TielschJTJames M. Tielsch
- John L. CameronJCJohn L. Cameron
- 1 September 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 228 (3) , 429-438
Abstract
To determine whether hospital volume is associated with clinical and economic outcomes for patients with pancreatic cancer who underwent pancreatic resection, palliative bypass, or endoscopic or percutaneous stent procedures in Maryland between 1990 and 1995. Previous studies have demonstrated that outcomes for patients undergoing a Whipple procedure improve with higher surgical volume, but only 20% to 35% of patients with pancreatic cancer qualify for curative resection. Most patients undergo palliative procedures instead with a surgical bypass or biliary stent. Analysis of hospital discharge data from all nonfederal acute care hospitals in Maryland identified all patients with pancreatic cancer who underwent a pancreatic resection, palliative bypass, or stent procedure between 1990 and 1995. Hospitals (n = 48) were categorized as high-, medium-, and low-volume providers according to their average annual volume of these procedures. Multivariate regression was used to examine the association between hospital volume and in-hospital mortality rate, length of stay, and hospital charges, after adjusting for differences in case mix and surgeon volume. Increased hospital volume is associated with markedly decreased in-hospital mortality rates and a decreased or similar length of stay for all three types of procedures and with decreased or similar hospital charges for resections and stents. After adjustment for case mix differences, the relative risk (RR) of in-hospital death after pancreatic resection was 19.3 and 8 at the low- and medium-volume hospitals, respectively, versus the high-volume hospital; after bypasses, the RR of death was 2.7 and 1.9, respectively; and after stents, the RR was 4.3 and 4.8, respectively. Patients with pancreatic cancer who are to be treated with curative or palliative procedures appear to benefit from referral to a high-volume provider.Keywords
This publication has 22 references indexed in Scilit:
- Molecular Biology and the Diagnosis and Treatment of Adenocarcinoma of the PancreasAdvances in Anatomic Pathology, 1996
- The Whipple Resection for Cancer in U.S. Department of Veterans Affairs HospitalsAnnals of Surgery, 1995
- The Effects of Regionalization on Cost and Outcome for One General High-Risk Surgical ProcedureAnnals of Surgery, 1995
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993
- Chemical Splanchnicectomy in Patients with Unresectable Pancreatic Cancer A Prospective Randomized TrialAnnals of Surgery, 1993
- Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality?1992
- Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitalsJAMA, 1989
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- The Relation Between Surgical Volume and Mortality: An Exploration of Causal Factors and Alternative ModelsMedical Care, 1980
- Should Operations Be Regionalized?New England Journal of Medicine, 1979